Ambry Genetics has been setting the standard in genetic testing for 25 years. Meet with us at the ACOG district meeting, and discover the impact that hereditary cancer testing can make for patients in an OB-GYN setting. #ACOG #breastcancer #OBGYN #genetictesting
Ambry Genetics
Biotechnology Research
Aliso Viejo, CA 67,786 followers
Finding Answers Through Quality Genetic Testing
About us
Ambry Genetics is a company built by scientists, genetic counselors and physicians, dedicated to leading the clinical genomic diagnostic industry. Ambry boasts the largest genetic sequencing lab in the world; is CAP-accredited, CLIA-licensed and, as part of the Konica Minolta family, has access to the most complete suite of diagnostic technology in the world. Ambry Genetics' scope of clients includes some of the world's most respected academic institutions, pharmaceutical companies and leading treatment hospitals. Our experience, technology and dedication to science make us a trusted source for all clinical genetic testing, and an ideal partner for developing precision medicine solutions. Patients are at the core of everything we do, which is why Ambry partners with several non-profit organizations so that we can help both patients and clinicians alike find answers. Hiring Fraud Alert: Ambry/REALM IDx has received reports of employment scams in recent months that seek financial commitments, or requests personal information from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email or text from individual(s) posing to be or represent Ambry/REALM IDx recruiter(s). If you’ve experienced either of these scenarios, please visit this page to learn more about hiring fraud: https://consumer.ftc.gov/articles/job-scams. Or visit https://realmidx.com/careers/recruitment-fraud-alert/ to learn more about our policy on recruitment fraud. You can confirm the legitimacy of a job posting by viewing our current open roles at https://realmidx.com/careers/.
- Website
-
https://www.ambrygen.com
External link for Ambry Genetics
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Aliso Viejo, CA
- Type
- Privately Held
- Founded
- 1999
- Specialties
- Molecular Diagnostic Testing, Clinical Diagnostic Exome, Breast Cancer Genetics, Hereditary Cancer, Cardio Genetics, Neuro Genetics, General Genetics, Family History Questionnaire, Pedigree Drawing Tool, and Risk Assessment Tool
Locations
-
Primary
1 Enterprise
Aliso Viejo, CA 92656, US
-
7 Argonaut
Aliso Viejo, CA 92656, US
Employees at Ambry Genetics
Updates
-
Ambry is proud to be the first lab to offer paired DNA and RNA testing for hereditary cancer. Approximately 1 in 50 hereditary cancer patients would be missed without + RNAinsight™. Learn more: https://hubs.ly/Q02FV1th0.
-
-
Are you a recent Genetic Counseling grad? Are you registered for tomorrow's Genetic Counseling Boards Review? https://hubs.ly/Q02FV2hw0 All sessions feature the same content, so there are two more chances if you can't make it! #genechat #geneticcounseling #boardsreview
-
-
Check out our guest blog series with Adrianne Alexander, RN, BSN, CBC. In part two, she shares practical, engaging, and impactful best practices to expand a high-risk breast program. #breastcancer #genetictesting #CARE https://hubs.ly/Q02GlJsL0
-
-
Ambry’s Classifi™ program represents a commitment to our clients to provide them with the highest quality test results, but Ambry’s no-stone-left-unturned commitment is not new. In fact, it is the reason so many people have trusted us for 25 years. Our Classifi program is simply putting a name to the layers of our expertise, our process and our use of cutting-edge technology to show our clients how we’ve always been different. Here, Dr. Kelly McGoldrick describes how an Ambry-initiated variant reclassification project provided updated results for over 7500 hereditary cancer testing patients. #Classifi #Ambry25 https://hubs.ly/Q02FRvbF0
Ambry Classifi
https://vimeo.com/
-
Did you know Ambry's Patient for Life program isn't just for exome testing? Neurological panels like NeurodevelopmentNext™ and EpilepsyNext-Expanded™ also qualify for proactive analysis to account for new gene disease associations, providing updated diagnoses to patients who receive expanded neurogenetics panels at Ambry. Genetic Counselor Victoria Suslovitch shares how one patient with a ZBTB20 mutation received answers. #PatientforLife #neurogenetics #AmbryKnowsGenes
-
Check out today's podcast episode of DNA Today with Ambry's Dr. Elizabeth Chao and Kelly Hagman!
🔬 We dive into how #exomes are continuously analyzed through Ambry Genetics' “Patient for Life” program! 🧬 🎙️ Episode #295 of the DNA Today podcast explores the incredible advancements in exome sequencing with Ambry Genetics' “Patient for Life” program. Join Elizabeth Chao, MD, FACMG and Kelly Hagman, MS, CGC as they discuss how continuous reanalysis improves patient care. Search “DNA Today” in your podcast player and stream Episode 295 🎧 https://lnkd.in/e3FQHDyc #Genetics #ExomeSequencing #PatientCare #SciencePodcast
-
In her role as a breast health navigator in a large health system, Adrianne Alexander was tasked with the development of a high-risk breast cancer program. She was thankful to find the right partner in the Ambry CARE Program®. We love to work with providers like Adrianne to ensure more patients have access to high risk screening, genetic testing, and genetic counseling as part of their healthcare journeys. #breastcancer #genetictesting #CARE
-
-
Join us for a webinar, Thursday, July 11, 2024, at 11:00am PDT. https://hubs.ly/Q02FY7Ls0
-
-
The Ambry Classifi™️ Program is committed to providing the right answer, the first time. Our variant classification team leverages the best of both people and process to ensure an advanced scientific approach. Hear more from Dr. Rhonda Lassiter, leader of the Genomic Science Development Program at Ambry. Learn more and watch the full video here: https://hubs.ly/Q02FHmXW0